Are Payers Putting Your Infusion Revenue at Risk?
Why Payer Mix Isn’t the Whole Story Many oncology practices evaluate financial performance based on payer mix – Medicare, commercial, Medicaid, […]
Growing Your Infusion Center With Growing Staffing Challenges
The Growth Challenge Facing Oncology Infusion Centers Community oncology practices and infusion centers are experiencing steady growth driven by: An aging […]
Why Oncology RCM Cannot Operate in Silos Anymore
The Hidden Cost of Fragmented Oncology Revenue Cycle Management Oncology revenue cycle management (RCM) is uniquely complex. Between chemotherapy drug billing, […]
Closing the Gap Between Authorization Approval and Payment in Oncology
In oncology, prior authorization is a critical step in ensuring patients receive timely, life-saving care. Given the high cost and complexity of treatments such as […]
Oncology Prior Authorization: Turning a Complex Process into a Strategic Revenue Advantage
Prior authorization has long been viewed as a necessary but burdensome administrative step in healthcare. In oncology, that perspective is quickly becoming outdated. As treatment costs […]
Top 5 Ways Infusion Centers Strengthen Revenue for Oncology Practices
Infusion therapy sits at the center of modern oncology care. It is where many of the most advanced treatments are delivered and where […]
From Data to Dominance: Strengthening Oncology Payer Contract Negotiations with RCM Intelligence
In oncology, payer contracts carry exceptional weight. Drug acquisition costs are high. Treatment regimens are complex. Authorization requirements are rigorous. Even small […]
Why Manual RCM Processes Don’t Work for Oncology Practices Anymore
Oncology practices operate in one of the most complex reimbursement environments in healthcare. High-cost drug regimens, evolving payer requirements, prior authorizations, modifier rules, and frequent […]
How Prior Authorization Bottlenecks Are Disrupting Oncology Care and Cash Flow
In oncology, delays are not just administrative. They are personal, clinical, and consequential. Every day spent waiting on prior authorization can mean postponed treatment, […]
Unseen, Unchecked, Unrecovered: Revenue Leakage in Oncology
After understanding the financial vulnerability facing oncology practices, the next critical question becomes unavoidable: where is revenue actually being lost, and why is it […]
